Skip to main content
Premium Trial:

Request an Annual Quote

Waters Sells $200M in Senior Notes, March 16, 2011

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Waters disclosed in a filing with the US Securities and Exchange Commission Wednesday that it has privately placed $200 million of senior notes with institutional investors.

The firm sold three series of notes: $50 million of Series C Senior Notes with a fixed rate interest of 2.5 percent and maturing on March 15, 2016; $100 million of Series D Senior Notes with an interest rate of 3.22 percent and maturing on March 15, 2018; and $50 million of Series E Senior Notes with an interest rate of 3.97 percent and maturing on March 15, 2021.

Waters said that it will use proceeds from the offering to repay other outstanding debt and for general corporate purposes.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.